When the effect persists: a rare case of sustained response to lenvatinib two years after discontinuation in papillary thyroid carcinoma
Year: 2026
Type: conference-abstract
Source: Endocrine Abstracts
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7204755968
